Purchases and Sales Made in Q3 2024 in Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW) during Q3 2024. The information is specifically focused on institutions that hold shares of NEUROSENSE THERAPEUTICS LTD WT.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Clear Street LLC
|
BUY
|
- |
6.49K+ 10.94% |
$843 - $1.75K
|
65.8K
$13.2K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-405- 66.94% |
$52.7 - $109
|
200
$40
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-4.19K- 14.22% |
$545 - $1.13K
|
25.3K
$5.05K
|
|
|
Nov 06, 2024
Q3 2024
|
Warberg Asset Management LLC
Winnetka, IL |
SELL
|
- |
-11.8K- 36.88% |
$1.53K - $3.19K
|
20.2K
$4.04K
|